Meyka AI API is live for developers.Start building.
Advertisement
Mallinckrodt plc

Mallinckrodt plc (MNK) Stock Overview

Explore Mallinckrodt plc’s financial performance, market position, analyst ratings, and future outlook.

MNKAMEX
HealthcareDrug Manufacturers - Specialty & Generic
$0.34
$0.06(14.97%)
U.S. Market opens in 41h 38m
Advertisement

Mallinckrodt plc (MNK)

Meyka AI Score

Z

Key Financials

Market Cap4.5M
P/E Ratio-0.02
EPS (TTM)$-0.78
ROE-0.26%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

MNK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mallinckrodt plc (MNK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 4.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
207.32%
1-Month Change
-14.97%
3-Month Change
-74.03%
6-Month Change
-95.77%
Year-to-Date (YTD) Change
-95.62%
1-Year Change
-97.80%
3-Year Change
-97.80%
5-Year Change
-97.80%
All-Time (Max) Change
-97.80%

Contact Information

353 1 696 0000
College Business & Technology Park, Dublin, NaN, 15

Company Facts

26,730 Employees
IPO DateJun 21, 2022
CountryIE

Frequently Asked Questions